HighMark Wealth Management’s Health Catalyst HCAT Stock Holding History

HighMark Wealth Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Sell	871,082 -32,000	-4%	-$46.2K	0.58%	28
2026 Q1	$1.13M	Buy	903,082 +161,600	+22%	+$304K	0.46%	31
2025 Q4	$1.77M	Buy	741,482 +431,200	+139%	+$1.18M	0.72%	21
2025 Q3	$884K	Buy	310,282 +145,532	+88%	+$498K	0.39%	34
2025 Q2	$621K	Buy	164,750 +163,500	+13,080%	+$643K	0.3%	42
2025 Q1	$5.66K	Hold	1,250	–	–	﹤0.01%	357
2024 Q4	$8.84K	Hold	1,250	–	–	0.01%	302
2024 Q3	$10.2K	Hold	1,250	–	–	0.01%	297
2024 Q2	$7.99K	Hold	1,250	–	–	﹤0.01%	322
2024 Q1	$9.41K	Hold	1,250	–	–	0.01%	287
2023 Q4	$11.6K	Hold	1,250	–	–	0.01%	247
2023 Q3	$12.7K	Hold	1,250	–	–	0.01%	234
2023 Q2	$15.6K	Hold	1,250	–	–	0.01%	206
2023 Q1	$14.6K	Hold	1,250	–	–	0.01%	243
2022 Q4	$13.3K	Hold	1,250	–	–	0.01%	215
2022 Q3	$12K	Buy	1,250 +1,000	+400%	+$13.2K	0.01%	218
2022 Q2	$4K	Hold	250	–	–	﹤0.01%	373
2022 Q1	$7K	Hold	250	–	–	﹤0.01%	320
2021 Q4	$10K	Sell	250 -395	-61%	-$18K	0.01%	255
2021 Q3	$32K	Buy	645 +54	+9%	+$2.94K	0.02%	144
2021 Q2	$33K	Sell	591 -142	-19%	-$7.57K	0.02%	147
2021 Q1	$34K	Sell	733 -183	-20%	-$8.86K	0.03%	129
2020 Q4	$40K	Sell	916 -1,012	-52%	-$37.3K	0.03%	108
2020 Q3	$71K	Buy	1,928 +1,413	+274%	+$48K	0.06%	85
2020 Q2	$15K	Buy	+515	New	+$14.2K	0.02%	161

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighMark Wealth Management's HCAT Position: Q2 2026 in Review

HighMark Wealth Management reduced its Health Catalyst (HCAT) stake by 3.5% in Q2 2026, selling an estimated $46.2K and leaving 871,082 shares worth $1.73M. The position accounts for 0.58% of the portfolio, ranked #28.

HighMark Wealth Management first reported a position in HCAT in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.77M in Q4 2025. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

HighMark Wealth Management held 871,082 shares of Health Catalyst worth $1.73M as of Q2 2026.
HighMark Wealth Management sold 32,000 Health Catalyst shares in Q2 2026, an estimated $46.2K.
Health Catalyst made up 0.58% of HighMark Wealth Management's portfolio in Q2 2026, its #28 holding.
HighMark Wealth Management first reported a position in Health Catalyst in Q2 2020 and has held it in 25 quarters since.
HighMark Wealth Management's Health Catalyst position peaked at $1.77M in Q4 2025.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.